Suchergebnisse - "Imperiale, Thomas F"

PubPharm (303)

1

Multitarget Stool RNA Testing

enthalten in: JAMA | 2024

von Imperiale, T. | Lavin, P. | Ransohoff, D.

CommentOn: JAMA. 2023 Nov 14;330(18):1760-1768. - PMID 37870871

2

Patient Navigation Plus Tailored Digital Video Disc Increases Colorectal Cancer Screening Among Low-Income and Minority Patients Who Did Not Attend a Scheduled Screening Colonoscopy : A Randomized Trial

enthalten in: Annals of behavioral medicine : a publication of the Society of Behavioral Medicine | 2024

von Rawl, S. | Perkins, S. | Tong, Y. | +14

3

Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening

enthalten in: The New England journal of medicine | 2024

von Imperiale, T. | Porter, K. | Zella, J. | +111

4

Closing a Gap in Colorectal Cancer Screening

enthalten in: JAMA network open | 2024

von Maratt, J. | Leiman, D. | Imperiale, T.

5

Colorectal Cancer Screening Programs in Latin America : A Systematic Review and Meta-Analysis

enthalten in: JAMA network open | 2024

von Montalvan-Sanchez, E. | Norwood, D. | Dougherty, M. | +5

6

CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life

enthalten in: Annals of internal medicine | 2024

von Imperiale, T.

CommentOn: JAMA Intern Med. 2023 Nov 1;183(11):1196-1203. - PMID 37639247

7

Risk Factors for Early-onset Sporadic Colorectal Cancer in Male Veterans

enthalten in: Cancer prevention research (Philadelphia, Pa.) | 2023

von Imperiale, T. | Myers, L. | Barker, B. | +3

CommentIn: Cancer Prev Res (Phila). 2023 Sep 1;16(9):479-481. - PMID 37655450

8

Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids

enthalten in: Mayo Clinic proceedings. Innovations, quality & outcomes | 2023

von Ebner, D. | Rushlow, D. | Mou, J. | +5

9

Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability

enthalten in: Genes & diseases | 2023

von Xie, J. | Nguyen, C. | Turk, A. | +5

10

Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial

enthalten in: JAMA network open | 2023

von Robertson, D. | Dominitz, J. | Beed, A. | +196

ErratumIn: JAMA Netw Open. 2023 Aug 1;6(8):e2330304. - PMID 37566425

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]